Senior Lecturer, Institute of Cellular Medicine, Newcastle University
Dr Xiao-nong Wang’s research aims to improve the safety and efficacy of cellular therapies via investigating the mechanisms of action of Treg therapy for graft-versus host disease and MSC therapy for early stage osteoarthritis. Current running research projects include “Modulation of osteo-chondrogenesis by MSC-derived extracellular vesicles” and “Modulation of GvHD by Treg-derived extracellular vesicles”
